AGM/EGMNov 4, 2026, 05:17 PM
GRI Bio Stockholders Approve Equity Plan Amendment, Elect Directors
AI Summary
GRI Bio, Inc. held its 2026 Annual Meeting of Stockholders where shareholders approved an amendment to the Amended and Restated 2018 Equity Incentive Plan. This amendment increases the number of shares reserved for issuance by 546,529 and extends the evergreen provision to January 1, 2036. Additionally, W. Marc Hertz, Ph.D. and David Szekeres were elected as Class III directors, and WithumSmith+Brown, PC was ratified as the independent registered public accounting firm. A quorum of approximately 42.37% of eligible shares was present.
Key Highlights
- GRI Bio, Inc. stockholders approved an amendment to the 2018 Equity Incentive Plan, increasing shares by 546,529 and extending the evergreen provision to January 1, 2036.
- W. Marc Hertz, Ph.D. and David Szekeres were elected as Class III directors.
- WithumSmith+Brown, PC was ratified as the independent registered public accounting firm for fiscal year ending December 31, 2026.
- The Company's 2026 Annual Meeting of Stockholders saw approximately 42.37% of eligible shares present.
- Proposal 3 to amend the Equity Incentive Plan received 136,205 'For' votes and 102,978 'Against' votes.
Price Impact
More from GRI